Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Oncology

Topics

Physics

Optics

Medicine

Immunology

Internal Medicine

Show all topics

DOI

10.1016/s1470-2045(09)70225-6